Davita Inc vs Emerson Electric Co. — how do they compare? Davita Inc trades at $175.04 (market cap $11.28B), while Emerson Electric Co. trades at $159.1 (market cap $88.81B). The key difference: Emerson Electric Co. is far larger — about 7.9× Davita Inc's market cap, and Emerson Electric Co. pays a 1.39% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Emerson Electric Co. for 81 Days on average.
| DVA | EMR | |
|---|---|---|
Market Cap | $11.28B | $88.81B |
Volume | 650,294 | 3,037,094 |
Sector | Health | Industrials |
52-Week High | $240.96 | $164.38 |
52-Week Low | $103.87 | $123.30 |
Typical Hold Time | 113 Days | 81 Days |
Enterprise Value | $24.00B | $99.89B |
Dividend Yield | — | 1.39% |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, down 1.87% on the day, showing mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company demonstrates strong earnings beats with Q2 2026 EPS of $4.02 exceeding expectations of $3.88, while revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026. Recent developments include expanding value-based care partnerships with Humana, potentially benefiting over 10,000 Medicare Advantage members.
The outlook remains cautiously optimistic with 43% analyst buy ratings and a $235.67 consensus price target suggesting 33% upside. However, rising debt-to-asset ratios (65.55% in 2025) and margin pressures from Q2 2026 create headwinds. Key risks include regulatory changes in healthcare reimbursement and competitive pressures in dialysis services.
Emerson Electric (EMR) trades at $159.06, down 1.44% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $165.90. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $1.84. Revenue and net income are projected to grow in 2026, supported by strong profitability margins including a 53.16% gross margin and 13.83% net margin.
The outlook for EMR is positive, with analyst sentiment leaning bullish (53.49% buy ratings) and technical indicators supporting upward momentum. Key risks include fluctuating cash flows and debt levels, while opportunities lie in continued earnings outperformance and solid fundamentals. The stock presents a favorable risk-reward profile near current levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Emerson Electric is a multi-industrial conglomerate that operates under two business platforms: automation solutions and commercial and residential solutions. The latter is further subdivided into two operating segments: climate technologies, which sells HVAC and refrigeration products and services as well as tools and home products, which sells tools and compressors, among other products and services. Commercial and residential solutions boasts several household brands, including Copeland and RIDGID. Automation solutions is most known for its process manufacturing solutions, which consists of measurement instrumentation, as well as valves and actuators, among other products and services. Roughly half of the firm's geographic sales take place in the United States.
Read more on EMR →